Biontech

Latest Stories

Prime Minister Justin Trudeau leaves a news conference in Ottawa, Monday, Dec. 7, 2020. (Adrian Wyld/The Canadian Press via AP)

Canada health regulator approves Pfizer’s COVID-19 vaccine

By ROB GILLIES - Associated Press

A nurse holds a phial of the Pfizer-BioNTech COVID-19 vaccine at Guy's Hospital in London, Tuesday, Dec. 8, 2020. U.K. health authorities rolled out the first doses of a widely tested and independently reviewed COVID-19 vaccine Tuesday, starting a global immunization program that is expected to gain momentum as more serums win approval. (AP Photo/Frank Augstein, Pool)

UK investigates possible allergic reactions to COVID-19 shot

Associated Press

FILE - In this April 2, 2020, file photo taken through a tinted car window, a technician takes a nasal swab for a coronavirus detection test at a drive-thru testing facility in Abu Dhabi, United Arab Emirates. The United Arab Emirates said Wednesday, Dec. 9, 2020, that a Chinese coronavirus vaccine by Sinopharm tested in the federation of sheikhdoms is 86% effective, though it released few details. (AP Photo/Jon Gambrell, File)

Israel’s Netanyahu: Vaccination campaign to begin Dec. 27

By JON GAMBRELL and JOSEF FEDERMAN - Associated Press

German Chancellor Angela Merkel (CDU), arrives in a car at the parliament for the beginning of the budget week in Berlin, Germany, Tuesday, Dec. 8, 2020. (Michael Kappeler/dpa via AP)

German states tighten virus rules as pandemic battle falters

By FRANK JORDANS - Associated Press

South Korean police officers wearing face masks and face shields to help protect against the spread of the coronavirus stand guard as protesters wait for the arrival of U.S. Deputy Secretary of State Stephen Biegun in front of Foreign Ministry in Seoul, South Korea, Wednesday, Dec. 9, 2020. (AP Photo/Ahn Young-joon)

Asia Today: S. Korea sees 686 new cases, 2nd-biggest spike

Associated Press

A city worker offers antibacterial gel to passing shoppers as they walk in a crowded commercial district of central Mexico City, Saturday, Dec. 5, 2020. With hospitals once again filling up with COVID-19 patients, Mexico City's mayor on Friday urged people to stay at home as much as possible and authorized checkpoints to limit the number of people entering the capital's colonial-era downtown at one time. (AP Photo/Rebecca Blackwell)

Mexico to launch COVID-19 vaccinations this month

Associated Press

FILE - This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. Pfizer’s COVID-19 vaccine is entering the final phase of review by U.S. government regulators. The Food and Drug Administration on Tuesday, Dec. 8 released a positive review of the vaccine. (Courtesy of University of Maryland School of Medicine via AP, File)

EXPLAINER: Final steps in US review of COVID-19 vaccine

By MATTHEW PERRONE - Associated Press

A nurse administers the Pfizer-BioNTech COVID-19 vaccine at Guy's Hospital in London, Tuesday, Dec. 8, 2020. U.K. health authorities rolled out the first doses of a widely tested and independently reviewed COVID-19 vaccine Tuesday, starting a global immunization program that is expected to gain momentum as more serums win approval. (AP Photo/Frank Augstein, Pool)

Pfizer vaccine moves closer to getting the OK in the US

By LAURAN NEERGAARD and MATTHEW PERRONE - Associated Press

A sign regarding mask use to help curb the spread of COVID-19 hangs outside a business in Vancouver, British Columbia, Sunday, Dec. 6, 2020. (Darryl Dyck/The Canadian Press via AP)

Trudeau: Canada to get Pfizer vaccine by end of this year

By ROB GILLIES - Associated Press

Margaret Keenan, 90, the first patient in the UK to receive the Pfizer-BioNTech COVID-19 vaccine, administered by nurse May Parsons at University Hospital, Coventry, England, Tuesday, Dec. 8, 2020. The United Kingdom, one of the countries hardest hit by the coronavirus, is beginning its vaccination campaign, a key step toward eventually ending the pandemic. (Jacob King/Pool via AP)

Britain coronavirus vaccinations to give U.S. answers to shot biggest questions

By Tom Howell Jr. - The Washington Times

Trudeau says Canada to get 250,000 doses of the vaccine developed by Pfizer and BioNTech before the

Associated Press

Nurses at the Royal Free Hospital, London, simulate the administration of the Pfizer vaccine to support staff training ahead of the rollout, in London, Friday Dec. 4, 2020. (Yui Mok/Pool Photo via AP)

UK gears up for huge vaccination plan watched by the world

By PAN PYLAS - Associated Press

FILE - This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. If big bad COVID-19 is ever to be knocked down, it just might take Diane Durand, a plucky grandmother from St. Simons Island to do it. (University of Maryland School of Medicine via AP, File)

St. Simons grandmother takes a shot in COVID-19 fight

By LARRY HOBBS and The Brunswick News - Associated Press

The construction of a planned vaccination center is presented by the Berlin authorities during a media event at the 'Arena Berlin' event venue in Berlin, Germany, Thursday, Dec. 3, 2020. Berlin city authorites will set up six vaccine center until the end of the month. (AP Photo/Markus Schreiber)

Germany readies vaccine centers amid security concerns

Associated Press

This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. Pfizer and BioNTech say they've won permission Wednesday, Dec. 2, 2020, for emergency use of their COVID-19 vaccine in Britain, the worlds first coronavirus shot thats backed by rigorous science -- and a major step toward eventually ending the pandemic. (Courtesy of University of Maryland School of Medicine via AP, File)

Bahrain approves Pfizer coronavirus vaccine; second country to do so

By Shen Wu Tan - The Washington Times

FILE - This Nov. 12, 2020 selfie photo provided by the Renown Regional Medical Center shows Dr. Jacob Keeperman, the Renown Transfer and Operations Center medical director who made the photo on the opening day of the Renown Regional Medical Center's alternative care site located in a parking garage. On Friday, Dec. 4, 2020, The Associated Press reported on stories circulating online incorrectly asserting this photo at an auxiliary care site for COVID-19 patients proves that the coronavirus pandemic is a hoax. The photo, which shows empty hospital beds, was taken the day the site was opened, and patients had yet to arrive. (Jacob Keeperman/Renown Regional Medical Center via AP)

NOT REAL NEWS: A look at what didn’t happen this week

By The Associated Press - Associated Press

FILE - In this Dec. 4, 2020 file photo, a general view of the Pfizer Manufacturing plant in Puurs, Belgium. The island kingdom of Bahrain says it has become the second nation in the world to grant emergency-use authorization for the coronavirus vaccine made by Pfizer and its German partner BioNTech. The state-run Bahrain News Agency made the announcement on Friday. (AP Photo/Olivier Matthys)

Bahrain now 2nd nation to grant Pfizer shot emergency use

By JON GAMBRELL - Associated Press

Bahrain says it is granting emergency-use authorization for coronavirus vaccine made by Pfizer, Germ

Associated Press

People eat outside in Covent Garden market, as non-essential shops are allowed to reopen after England's second lockdown ended in London, Wednesday, Dec. 2, 2020. Pfizer and BioNTech say they've won permission Wednesday for emergency use of their COVID-19 vaccine in Britain, the world's first coronavirus shot that's backed by rigorous science -- and a major step toward eventually ending the pandemic.(AP Photo/Alberto Pezzali)

Q&A: Britain’s OK of COVID-19 vaccine sparks speedy debate

By DANICA KIRKA - Associated Press

In this undated photo released by Pfizer on Tuesday, Dec. 1, 2020, a vial of the COVID-19 candidate vaccine developed by BioNTech and Pfizer is shown displayed at the headquarters in Puurs, Belgium. The vaccine is awaiting approval to use against the coronavirus. (Pfizer via AP)

Belgium looks to launch limited vaccine campaign in January

Associated Press